190 related articles for article (PubMed ID: 30389727)
1. Evaluating the Evidence behind Policy Mandates in US Dialysis Care.
Erickson KF; Winkelmayer WC
J Am Soc Nephrol; 2018 Dec; 29(12):2777-2779. PubMed ID: 30389727
[No Abstract] [Full Text] [Related]
2. Futuristic plans for ESRD--a new bundled payment system.
Michael M
Nephrol News Issues; 2005 Sep; 19(10):52, 54. PubMed ID: 16187649
[No Abstract] [Full Text] [Related]
3. End stage renal disease and Medicare.
Greer JW
Health Care Financ Rev; 2003; 24(4):1-5. PubMed ID: 14628396
[No Abstract] [Full Text] [Related]
4. Medicare and erythropoietin.
Steinbrook R
N Engl J Med; 2007 Jan; 356(1):4-6. PubMed ID: 17202449
[No Abstract] [Full Text] [Related]
5. Conditions for coverage fail to relieve administrative burden.
Wish D
Nephrol News Issues; 2005 Sep; 19(10):46-7, 51. PubMed ID: 16187648
[No Abstract] [Full Text] [Related]
6. Bundled payment for ESRD--including ESAs in Medicare's dialysis package.
Iglehart JK
N Engl J Med; 2011 Feb; 364(7):593-5. PubMed ID: 21323538
[No Abstract] [Full Text] [Related]
7. Medicare program; end-stage renal disease prospective payment system. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2010 Aug; 75(155):49029-214. PubMed ID: 20712086
[TBL] [Abstract][Full Text] [Related]
8. Palliative dialysis in end-stage renal disease.
Trivedi DD
Am J Hosp Palliat Care; 2011 Dec; 28(8):539-42. PubMed ID: 21398269
[TBL] [Abstract][Full Text] [Related]
9. Important legal, regulatory issues impacting renal care in 2008.
Riley J; Pristave R
Nephrol News Issues; 2008 Dec; 22(13):48-9. PubMed ID: 19149317
[No Abstract] [Full Text] [Related]
10. Special treatment--the story of Medicare's ESRD entitlement.
Rettig RA
N Engl J Med; 2011 Feb; 364(7):596-8. PubMed ID: 21323539
[No Abstract] [Full Text] [Related]
11. Erythropoietin & ESRD payments: a promising policy outcome?
Roe W
Nephrol News Issues; 1989 Sep; 3(9):34-5. PubMed ID: 2682270
[No Abstract] [Full Text] [Related]
12. What can we expect down the road?
Sullivan J
Nephrol News Issues; 2011 Apr; 25(4):28-9. PubMed ID: 21542511
[No Abstract] [Full Text] [Related]
13. Are cost pressures influencing the way nephrologists provide care?
Dubman R
Nephrol News Issues; 2014 Mar; 28(3):22, 24, 33. PubMed ID: 24720012
[No Abstract] [Full Text] [Related]
14. Helping patients with end-stage renal disease.
Kuchta K; VanBuskirk S; Houglum M
Am J Nurs; 2007 May; 107(5):35-6. PubMed ID: 17443073
[No Abstract] [Full Text] [Related]
15. Bundling and its potential impact on dialysis service providers.
Sullivan J
Nephrol News Issues; 2008 Oct; 22(11):12, 14, 16-7. PubMed ID: 19009855
[No Abstract] [Full Text] [Related]
16. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field?
Gardner AV
Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480
[No Abstract] [Full Text] [Related]
17. Understanding financial risk models: Implicationsfor nephrology practices and dialysis centers.
Cellini GL
Nephrol News Issues; 2016 Mar; 30(3):26-8, 30-3. PubMed ID: 27169216
[No Abstract] [Full Text] [Related]
18. Outpatient Dialysis for Acute Kidney Injury: Progress and Pitfalls.
Heung M
Am J Kidney Dis; 2019 Oct; 74(4):523-528. PubMed ID: 31204193
[TBL] [Abstract][Full Text] [Related]
19. The 2011 ESRD prospective payment system: welcome to the bundle.
Weiner DE
Am J Kidney Dis; 2011 Apr; 57(4):539-41. PubMed ID: 21333431
[No Abstract] [Full Text] [Related]
20. Payment of USA physicians for dialysis care.
Kliger AS; Finkelstein FO
Perit Dial Int; 2004; 24(6):518-20. PubMed ID: 15559477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
